144 related articles for article (PubMed ID: 37309723)
1. Proteomic analysis of the small extracellular vesicles and soluble secretory proteins from cachexia inducing and non-inducing cancer cells.
Chitti SV; Kang T; Fonseka P; Marzan AL; Stewart S; Shahi S; Bramich K; Ang CS; Pathan M; Gummadi S; Mathivanan S
Proteomics; 2023 Aug; 23(15):e2100314. PubMed ID: 37309723
[TBL] [Abstract][Full Text] [Related]
2. Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
Fan M; Gu X; Zhang W; Shen Q; Zhang R; Fang Q; Wang Y; Guo X; Zhang X; Liu X
J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2724-2739. PubMed ID: 36085573
[TBL] [Abstract][Full Text] [Related]
3. Exosomal IL-8 derived from Lung Cancer and Colon Cancer cells induced adipocyte atrophy via NF-κB signaling pathway.
Xiong H; Ye J; Xie K; Hu W; Xu N; Yang H
Lipids Health Dis; 2022 Dec; 21(1):147. PubMed ID: 36581870
[TBL] [Abstract][Full Text] [Related]
4. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
[TBL] [Abstract][Full Text] [Related]
5. Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell-derived factors.
Marzan AL; Chitti SV; Gummadi S; Kang T; Ang CS; Mathivanan S
Proteomics; 2023 Oct; ():e2300020. PubMed ID: 37882347
[TBL] [Abstract][Full Text] [Related]
6. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
7. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
8. Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90.
Zhang G; Liu Z; Ding H; Zhou Y; Doan HA; Sin KWT; Zhu ZJ; Flores R; Wen Y; Gong X; Liu Q; Li YP
Nat Commun; 2017 Sep; 8(1):589. PubMed ID: 28928431
[TBL] [Abstract][Full Text] [Related]
9. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway.
Hu W; Ru Z; Zhou Y; Xiao W; Sun R; Zhang S; Gao Y; Li X; Zhang X; Yang H
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Aug; 1864(8):1091-1102. PubMed ID: 31002945
[TBL] [Abstract][Full Text] [Related]
11. Unravelling the Role of Cancer Cell-Derived Extracellular Vesicles in Muscle Atrophy, Lipolysis, and Cancer-Associated Cachexia.
Marzan AL; Chitti SV
Cells; 2023 Nov; 12(22):. PubMed ID: 37998333
[TBL] [Abstract][Full Text] [Related]
12. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of extracellular vesicles in mediating cancer cachexia.
Chitti SV; Fonseka P; Mathivanan S
Biochem Soc Trans; 2018 Oct; 46(5):1129-1136. PubMed ID: 30242118
[TBL] [Abstract][Full Text] [Related]
15. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
[TBL] [Abstract][Full Text] [Related]
16. GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2/caspase-3 pathway.
Zhang W; Sun W; Gu X; Miao C; Feng L; Shen Q; Liu X; Zhang X
Cell Death Discov; 2022 Apr; 8(1):162. PubMed ID: 35379793
[TBL] [Abstract][Full Text] [Related]
17. The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia.
VanderVeen BN; Cardaci TD; Bullard BM; Huss AR; McDonald SJ; Muhammed AD; Kubinak JL; Fan D; Murphy EA
Am J Physiol Cell Physiol; 2024 Feb; 326(2):C606-C621. PubMed ID: 38189130
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice.
Niu M; Song S; Su Z; Wei L; Li L; Pu W; Zhao C; Ding Y; Wang J; Cao W; Gao Q; Wang H
Br J Pharmacol; 2021 Nov; 178(22):4485-4500. PubMed ID: 34265073
[TBL] [Abstract][Full Text] [Related]
19. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
20. Curcumin treatment suppresses cachexia-associated adipose wasting in mice by blocking the cAMP/PKA/CREB signaling pathway.
Wang R; Wei L; Wazir J; Li L; Song S; Lin K; Pu W; Zhao C; Su Z; Zhao Q; Wang H
Phytomedicine; 2023 Jan; 109():154563. PubMed ID: 36610148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
